Yi Hsu Huang
Director/Board Member presso ADVAGENE BIOPHARMA CO., LTD.
Profilo
Yi Hsu Huang was the founder of Mycenax Biotech, Inc. founded in 2001, where he held the title of Director from 2013 to 2019.
Currently, he is the Chief Executive Officer-Bioproduction Plant at National Health Research Institutes and a Director at Advagene Biopharma Co., Ltd.
since 2016.
He previously worked as the Chief Technology Officer & Deputy General Manager at Medigen Vaccine Biologics Corp.
Dr. Huang holds a doctorate degree from Auburn University and a graduate degree from Northwestern State University.
Posizioni attive di Yi Hsu Huang
| Società | Posizione | Inizio |
|---|---|---|
| ADVAGENE BIOPHARMA CO., LTD. | Director/Board Member | 06/04/2016 |
| National Health Research Institutes | Corporate Officer/Principal | - |
Precedenti posizioni note di Yi Hsu Huang
| Società | Posizione | Fine |
|---|---|---|
| MEDIGEN VACCINE BIOLOGICS CORPORATION | Chief Tech/Sci/R&D Officer | 01/05/2021 |
| MYCENAX BIOTECH INC. | Founder | 15/08/2019 |
Formazione di Yi Hsu Huang
| Auburn University | Doctorate Degree |
| Northwestern State University | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| MYCENAX BIOTECH INC. | Health Technology |
| MEDIGEN VACCINE BIOLOGICS CORPORATION | Health Technology |
| ADVAGENE BIOPHARMA CO., LTD. | Health Technology |
| Aziende private | 1 |
|---|---|
| National Health Research Institutes |
- Borsa valori
- Insiders
- Yi Hsu Huang
